Cargando…
Vpu and BST2: Still Not There Yet?
Extensive investigations have identified two cellular proteins in humans that potently inhibit HIV type 1 (HIV-1) replication and are widely accepted as “restriction factors.” APOBEC3G was identified as a restriction factor that diminishes HIV-1 replication by inducing G-to-A hypermutation in the vi...
Autores principales: | Sato, Kei, Gee, Peter, Koyanagi, Yoshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321438/ https://www.ncbi.nlm.nih.gov/pubmed/22509177 http://dx.doi.org/10.3389/fmicb.2012.00131 |
Ejemplares similares
-
Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function Approach
por: Yoshida, Takeshi, et al.
Publicado: (2011) -
Mechanistic study of BST-2 down-modulation by HIV-1 Vpu
por: Zhang, Jianyong, et al.
Publicado: (2009) -
2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation
por: Zhang, Quan, et al.
Publicado: (2016) -
Efficient BST2 antagonism by Vpu is critical for early HIV-1 dissemination in humanized mice
por: Dave, Vibhuti P, et al.
Publicado: (2013) -
Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
por: Jia, Bin, et al.
Publicado: (2009)